Correlation Between Terns Pharmaceuticals and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and ZyVersa Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and ZyVersa Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and ZyVersa Therapeutics
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Terns and ZyVersa is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and ZyVersa Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.64 times more return on investment than ZyVersa Therapeutics. However, Terns Pharmaceuticals is 1.56 times less risky than ZyVersa Therapeutics. It trades about 0.01 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 632.00 in Terns Pharmaceuticals on August 24, 2024 and sell it today you would lose (61.00) from holding Terns Pharmaceuticals or give up 9.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| ZyVersa Therapeutics |
Terns Pharmaceuticals and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and ZyVersa Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Terns Pharmaceuticals vs. ZyVersa Therapeutics | Terns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Terns Pharmaceuticals vs. Zura Bio Limited | Terns Pharmaceuticals vs. Phio Pharmaceuticals Corp |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |